ANDA User Fee Creation Is Among Top NAPM Legislative Issues For 2000
Executive Summary
The National Association of Pharmaceutical Manufacturers will press for the creation of generic drug user fees during the second session of the 106th Congress.
You may also be interested in...
Product Life Cycle Limits May Level Playing Field For Generics - TCI's DiCicco
Legislation that would limit branded product life cycle management strategies could level the playing field for generic drug products, Technology Catalysts International President Richard DiCicco said at the International Generic Drug Forum Jan. 24 in Washington, D.C.
Gore Pro-Generic Campaign Platform Includes Citizen Petition Restrictions
Vice President Gore is promising to address the potential for the FDA citizen petition process to be used to delay generic drug approvals if he is elected President.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011